James Allen Helliwell - Net Worth and Insider Trading
James Allen Helliwell Net Worth
The estimated net worth of James Allen Helliwell is at least $3 Million dollars as of 2024-11-13. James Allen Helliwell is the Director of Eupraxia Pharmaceuticals Inc and owns about 658,426 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) stock worth over $3 Million. Details can be seen in James Allen Helliwell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Allen Helliwell has not made any transactions after 2023-03-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Allen Helliwell
James Allen Helliwell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Allen Helliwell owns 1 companies in total, including Eupraxia Pharmaceuticals Inc (TSX:EPRX) .
Click here to see the complete history of James Allen Helliwell’s form 4 insider trades.
Insider Ownership Summary of James Allen Helliwell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:EPRX | Eupraxia Pharmaceuticals Inc | 2023-03-28 | Director |
James Allen Helliwell Latest Holdings Summary
James Allen Helliwell currently owns a total of 1 stock. James Allen Helliwell owns 658,426 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) as of March 28, 2023, with a value of $3 Million.
Latest Holdings of James Allen Helliwell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:EPRX | Eupraxia Pharmaceuticals Inc | 2023-03-28 | 658,426 | 4.00 | 2,633,704 |
Holding Weightings of James Allen Helliwell
James Allen Helliwell Form 4 Trading Tracker
According to the SEC Form 4 filings, James Allen Helliwell has made a total of 12 transactions in Eupraxia Pharmaceuticals Inc (TSX:EPRX) over the past 5 years, including 12 buys and 0 sells. The most-recent trade in Eupraxia Pharmaceuticals Inc is the acquisition of 4,800 shares on March 28, 2023, which cost James Allen Helliwell around $19,680.
Insider Trading History of James Allen Helliwell
- 1
James Allen Helliwell Trading Performance
GuruFocus tracks the stock performance after each of James Allen Helliwell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Allen Helliwell is -11.69%. GuruFocus also compares James Allen Helliwell's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Allen Helliwell within 3 months outperforms 3 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Allen Helliwell's insider trading performs compared to the benchmark.
Performance of James Allen Helliwell
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.34 | | | | | |
| Relative Return to S&P 500(%) | -3.92 | | | | | |
James Allen Helliwell Ownership Network
Ownership Network List of James Allen Helliwell
Ownership Network Relation of James Allen Helliwell
James Allen Helliwell Owned Company Details
What does Eupraxia Pharmaceuticals Inc do?
Who are the key executives at Eupraxia Pharmaceuticals Inc?
James Allen Helliwell is the Director of Eupraxia Pharmaceuticals Inc. Other key executives at Eupraxia Pharmaceuticals Inc include Senior Officer Amanda Michelle Malone , Senior Officer Paul Anthony Brennan , and Director or Senior Officer of 10% Security Holder James Besser .
Eupraxia Pharmaceuticals Inc (TSX:EPRX) Insider Trades Summary
Over the past 18 months, James Allen Helliwell made no insider transaction in Eupraxia Pharmaceuticals Inc (TSX:EPRX). Other recent insider transactions involving Eupraxia Pharmaceuticals Inc (TSX:EPRX) include a net purchase of 3,800 shares made by Michael Wilmink ,
In summary, during the past 3 months, insiders sold 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) in total and bought 1,900 shares, with a net purchase of 1,900 shares. During the past 18 months, 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) were sold and 3,800 shares were bought by its insiders, resulting in a net purchase of 3,800 shares.
Eupraxia Pharmaceuticals Inc (TSX:EPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eupraxia Pharmaceuticals Inc Insider Transactions
James Allen Helliwell Mailing Address
Above is the net worth, insider trading, and ownership report for James Allen Helliwell. Currently GuruFocus does not have mailing address information for James Allen Helliwell.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
